Q2 2026 · 1 tracked holders Snapshot · 16 Nov 2026 Export CSV
Security file · CUSIP 09075P204

BIOXCEL THERAPEUTICS INC

BIOXCEL THERAPEUTICS INC · held by 1 tracked manager in Q2 2026.

Tracked holders · Q2 2026
1
+0 vs Q1 2026
Aggregate reported value
$1.95M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q2 2026
ManagerWeight SharesΔ shares Entry Return ValueActivity
1 Howard Marks - Oaktree Capital Managementfiled 13 Aug ET 0.03% 1.38M +472.3% — — $1.95M Added
Holder count
Q2 2025Q3 2025Q4 2025Q1 2026Q2 20261
Aggregate reported value
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$1.95M
Quarterly aggregation
QuarterHoldersΔ holdersAggregate valueTotal shares
Q2 2026 1 +0 $1.95M 1.38M
Q1 2026 1 +0 $323K 241K
Q4 2025 1 +0 $386K 241K
Q3 2025 1 +0 $617K 241K
Q2 2025 1 — $437K 241K